Magnesium compositions and uses thereof
A composition for administration to a subject, such as oral administration to a subject, for example, has been provided. Such a composition may comprise at least one magnesium-counter ion compound. A magnesium-counter ion composition described herein may be useful for any of a variety of applications provided herein, such as maintaining, enhancing, and/or improving health, nutrition, and/or another condition of a subject, and/or cognitive, learning, and/or memory function. A magnesium-counter ion composition provided herein may be useful for administration to a subject presenting magnesium deficiency, mild cognitive impairment, Alzheimer's disease, attention deficit hyperactivity disorder, ALS, Parkinson's disease, diabetes, migraine, anxiety disorder, mood disorder, and/or hypertension. A kit, method, and other associated technology are also provided.
1. A composition for oral administration to a subject, comprising:
a. magnesium threonate; and
b. at least one component of non-acidified milk sufficient to enhance bioavailability of elemental magnesium of the magnesium threonate,
wherein a mass ratio of the amount of elemental magnesium of the magnesium threonate and the amount of the at least one component of said non-acidified milk is from about 1 to about 5 to about 1 to about 3000.
2. The composition of claim 1 , further comprising at least one magnesium comprising component (MCC) selected from magnesium citrate, magnesium gluconate, magnesium lactate, and magnesium malate.
3. The composition of claim 2 , further comprising from about 5 to about 50 percent magnesium citrate, from about 10 to about 70 percent magnesium gluconate, and from about 5 to about 50 percent magnesium lactate, wherein each percent is a weight percent relative to the total weight of the magnesium citrate, magnesium lactate and magnesium gluconate.
4. The composition of claim 1 , wherein the at least one component of said non-acidified milk comprises milk fat.
5. The composition of claim 1 , wherein the at least one component of said non-acidified milk comprises lactose.
6. The composition of claim 1 , wherein the at least one component of said non-acidified milk has a pH of from about 5.7 to about 7.2.
7. The composition of claim 1 , wherein the magnesium threonate is present in at least an amount effective for maintenance of cognitive function.
8. The composition of claim 1 , wherein the magnesium threonate is present in at least an amount effective for enhancement of cognitive function.
9. The composition of claim 1 , wherein the magnesium threonate is present in at least an amount effective for treatment of Alzheimer's disease.
10. The composition of claim 1 , wherein the composition is in a form selected from liquid, gel, semi-liquid, semi-solid, and solid.
11. The composition of claim 1 , wherein the composition is in a liquid form.
12. The composition of claim 11 , wherein the concentration of elemental magnesium associated with the magnesium threonate is from about 5 mg/L to about 12 g/L.
13. The composition of claim 1 , wherein the composition is sufficient to provide from about 1.5 mg/kg of body weight/day to about 18 mg/kg of body weight/day of elemental magnesium associated with the magnesium threonate.
14. An oral dosage form comprising magnesium threonate, wherein the oral dosage form comprises 300 mg to 1.5 g elemental magnesium.
15. The oral dosage form of claim 14 , wherein said oral dosage form is a tablet.
16. The oral dosage form of claim 14 , wherein said oral dosage form is a capsule.
17. The oral dosage form of claim 14 , wherein said oral dosage form is a liquid.
18. The oral dosage form of claim 14 , wherein said oral dosage form comprises a plurality of beads encapsulated in a capsule.
19. An oral dosage comprising a pharmaceutically active agent and an excipient, wherein the excipient is magnesium threonate, and wherein the oral dosage is solid or semi-solid.
20. A composition for oral administration to a subject, comprising:
magnesium threonate in an amount effective for maintenance and/or enhancement of cognitive function, wherein said composition is in a formulation suitable for oral administration to a subject.
21. The composition of claim 20 , wherein magnesium threonate is present in at least an amount effective for treatment of Alzheimer's disease.
22. The composition of claim 20 , further comprising at least one component of non-acidified milk sufficient to enhance bioavailability of elemental magnesium associated with magnesium threonate.
23. The composition of claim 22 , wherein the at least one component comprises milk fat.
24. The composition of claim 22 , wherein the at least one component comprises lactose.
25. The composition of claim 20 , wherein the composition is in a form selected from liquid, gel, semi-liquid, semi-solid, and solid.
26. The composition of claim 20 , wherein the composition is in a liquid form.
27. The composition of claim 20 , wherein the concentration of elemental magnesium in magnesium threonate is from about 5 mg/L to about 12 g/L.
28. The composition of claim 20 , wherein the composition is sufficient to provide from about 1.5 mg/kg of body weight/day to about 18 mg/kg of body weight/day of elemental magnesium.
29. A method of providing magnesium supplementation to a subject, comprising: orally administering to the subject the composition of claim 1 .